Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Terminated 3Completed 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1CNS 1Breast 1

Conditions

Pancreatic Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Carcinoma, Squamous Cell 1Breast Neoplasms, Male 1Breast Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 548pembrolizumab 386Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 316Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 273Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 173Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Has results × Dynamic Contrast Enhanced Magnetic Resonance Imaging × Clear all
NCT02372409 2024-11-01

Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors

Washington University School of Medicine

Phase 2 Terminated
6 enrolled 10 charts
CNS

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma, Optic Nerve Glioma

NCT01931709 2023-11-18

FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer

University of Washington

Phase NA Terminated
35 enrolled 11 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT02241187 2017-09-27

Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection

Memorial Sloan Kettering Cancer Center

Phase NA Completed
2 enrolled 4 charts
Gastrointestinal

Pancreatic Neoplasms

NCT00490061 2017-03-06

Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy

Stanford University

Phase 2 Terminated
17 enrolled 7 charts
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡